Page 1 | Search Results | Clinical Cancer Research | American Association for Cancer Research

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Abstract A017: Prevalence and significance of common molecular alterations in Tp53-mutated uterine serous carcinoma

Olivier Harismendy, Jianhui Ma, Adrian M. Jubb, Carrie Brownstein, Mark R. Lackner, Ramez N. Eskander, Joyce Liu, Shannon N. Westin

Clin Cancer Res (2024) 30 (5_Supplement): A017.

https://doi.org/10.1158/1557-3265.ENDO24-A017

Published: 01 March 2024

View articletitled, Abstract A017: Prevalence and significance of common molecular alterations in Tp53-mutated uterine serous carcinoma

Journal Articles

Abstract A66: Repeatome profiling in high-grade serous ovarian cancer reveals abundant repeat noncoding RNA expression

Rebecca L. Porter, Anna Szabolcs, Niyati Desai, Vishal Thapar, Raghav Mohan, Alexander Solovyov, David Pepin, Joyce Liu, Benjamin Greenbaum, David T. Ting

Clin Cancer Res (2020) 26 (13_Supplement): A66.

https://doi.org/10.1158/1557-3265.OVCA19-A66

Published: 01 July 2020

View articletitled, Abstract A66: Repeatome profiling in high-grade serous ovarian cancer reveals abundant repeat noncoding RNA expression

Journal Articles

Abstract AP19: SINGLE–CELL RNA–SEQUENCING OF PATIENT–DERIVED OVARIAN CANCER CELLS AND PATIENT–DERIVED XENOGRAFT MODELS

Benjamin Izar, Elizabeth Stover, Itay Tirosh, Asaf Rotem, Parin Shah, Chris Rodman, Sanjay Prakadan, Marc Wadsworth, Mei-Ju Su, Rachel Leeson, Sangeetha Palakurthi, Joyce Liu, Ursula Matulonis, Alex Shalek, Orit Rozenblatt-Rosen, Aviv Regev, Levi Garraway

Clin Cancer Res (2017) 23 (11_Supplement): AP19.

https://doi.org/10.1158/1557-3265.OVCASYMP16-AP19

Published: 31 May 2017

View articletitled, Abstract AP19: SINGLE–CELL RNA–SEQUENCING OF PATIENT–DERIVED OVARIAN CANCER CELLS AND PATIENT–DERIVED XENOGRAFT MODELS

Journal Articles

Abstract POSTER-BIOL-1345: SUSD2 inhibits spheroids from breaching the mesothelium: a mechanism for increased longevity of patients with SUSD2-expressing high-grade ovarian serous carcinoma

Jordan N. Sheets, Marcin Iwanicki, Joyce Liu, Ronny Drapkin, Kristi A. Egland

Clin Cancer Res (2015) 21 (16_Supplement): POSTER-BIOL-1345.

https://doi.org/10.1158/1557-3265.OVCASYMP14-POSTER-BIOL-1345

Published: 15 August 2015

View articletitled, Abstract POSTER-BIOL-1345: SUSD2 inhibits spheroids from breaching the mesothelium: a mechanism for increased longevity of patients with SUSD2-expressing high-grade ovarian serous carcinoma

Journal Articles

Abstract PR01: Adaptive resistance of patient-derived ovarian cancer cells to PI3K/mTOR inhibition

Ioannis Zervantonakis, Hsing-Yu Chen, Taru Muranen, Joyce Liu, Ronny Drapkin, Ursula Matulonis, Joan Brugge

Clin Cancer Res (2015) 21 (4_Supplement): PR01.

https://doi.org/10.1158/1557-3265.PMS14-PR01

Published: 13 February 2015

View articletitled, Abstract PR01: Adaptive resistance of patient-derived ovarian cancer cells to PI3K/mTOR inhibition

Journal Articles

New Strategies in Ovarian Cancer: Translating the Molecular Complexity of Ovarian Cancer into Treatment Advances

Joyce Liu, Ursula A. Matulonis

Clin Cancer Res (2014) 20 (20): 5150–5156.

https://doi.org/10.1158/1078-0432.CCR-14-1312

Published: 14 October 2014

View articletitled, New Strategies in Ovarian Cancer: Translating the Molecular Complexity of Ovarian Cancer into Treatment Advances

Journal Articles

Abstract A71: Expression of Sushi Domain Containing 2 (SUSD2) in high-grade ovarian serous carcinoma correlated with increased longevity of patients

Jennifer A. A. Gubbels, Elizabeth M. Hultgren, Jessica Johnson, Emily Johnson, Jeffrey Sachs, Michelle S. Hirsch, Joyce Liu, Ronny Drapkin, Kristi A. Egland

Clin Cancer Res (2013) 19 (19_Supplement): A71.

https://doi.org/10.1158/1078-0432.OVCA13-A71

Published: 13 May 2014

View articletitled, Abstract A71: Expression of Sushi Domain Containing 2 (SUSD2) in high-grade ovarian serous carcinoma correlated with increased longevity of patients

Journal Articles

Abstract IA3: In tumor screening for novel targets in papillary serous ovarian cancer

Maria Giuseppina Baratta, Maria Giuseppina Baratta, Joyce Liu, Joyce Liu, Yaara Zwang, Yaara Zwang, Yaara Zwang, Anna Schinzel, Anna Schinzel, Ronny Drapkin, Ronny Drapkin, William Hahn, William Hahn, William Hahn, David M. Livingston, David M. Livingston

Clin Cancer Res (2013) 19 (19_Supplement): IA3.

https://doi.org/10.1158/1078-0432.OVCA13-IA3

Published: 13 May 2014

View articletitled, Abstract IA3: In tumor screening for novel targets in papillary serous ovarian cancer

Journal Articles

Abstract A80: TNFAIP2 is required for growth and migration of ovarian cancer cells and functions to regulate trafficking of receptor tyrosine kinases

Sekhar Duraisamy, Keren Levanon, Guillaume Adelmant, Huiying Piao, Joyce Liu, Ursula Matulonis, Michelle Hirsch, Jarrod A. Marto, Ronny Drapkin

Clin Cancer Res (2013) 19 (19_Supplement): A80.

https://doi.org/10.1158/1078-0432.OVCA13-A80

Published: 13 May 2014

View articletitled, Abstract A80: TNFAIP2 is required for growth and migration of ovarian cancer cells and functions to regulate trafficking of receptor tyrosine kinases

Journal Articles

Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome

Clin Cancer Res (2012) 18 (20): 5806–5815.

https://doi.org/10.1158/1078-0432.CCR-12-0857

Published: 14 October 2012

View articletitled, Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome

Includes: Supplementary data

Journal Articles

Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian Cancer

Michael J. Callahan, Zoltan Nagymanyoki, Tomas Bonome, Michael E. Johnson, Babak Litkouhi, Elizabeth H. Sullivan, Michelle S. Hirsch, Ursula A. Matulonis, Joyce Liu, Michael J. Birrer, Ross S. Berkowitz, Samuel C. Mok

Clin Cancer Res (2008) 14 (23): 7667–7673.

https://doi.org/10.1158/1078-0432.CCR-08-0479

Published: 01 December 2008

View articletitled, Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian Cancer

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract A017: Prevalence and significance of common molecular alterations in Tp53-mutated uterine serous carcinoma

Abstract A66: Repeatome profiling in high-grade serous ovarian cancer reveals abundant repeat noncoding RNA expression

Abstract AP19: SINGLE–CELL RNA–SEQUENCING OF PATIENT–DERIVED OVARIAN CANCER CELLS AND PATIENT–DERIVED XENOGRAFT MODELS

Abstract POSTER-BIOL-1345: SUSD2 inhibits spheroids from breaching the mesothelium: a mechanism for increased longevity of patients with SUSD2-expressing high-grade ovarian serous carcinoma

Abstract PR01: Adaptive resistance of patient-derived ovarian cancer cells to PI3K/mTOR inhibition

New Strategies in Ovarian Cancer: Translating the Molecular Complexity of Ovarian Cancer into Treatment Advances

Abstract A71: Expression of Sushi Domain Containing 2 (SUSD2) in high-grade ovarian serous carcinoma correlated with increased longevity of patients

Abstract IA3: In tumor screening for novel targets in papillary serous ovarian cancer

Abstract A80: TNFAIP2 is required for growth and migration of ovarian cancer cells and functions to regulate trafficking of receptor tyrosine kinases

Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome

Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian Cancer

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only